<DOC>
	<DOC>NCT01900691</DOC>
	<brief_summary>The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.</brief_summary>
	<brief_title>Removal of the Evolution® Esophageal Stent - Fully Covered</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Esophageal Stenosis</mesh_term>
	<mesh_term>Esophageal Fistula</mesh_term>
	<mesh_term>Esophageal Perforation</mesh_term>
	<criteria>Patient is diagnosed with benign or malignant stricture, fistula, perforation, or leak Physician plans to remove the stent within the duration of study followup Patient is &lt; 18 years of age Patient is unable or unwilling to provide written informed consent or comply with followup schedule Patient is pregnant, lactating, or planning on being pregnant within the next 6 months Patient is simultaneously participating in another investigational drug or device study Patient that is contraindicated to upper GI endoscopy and/or any procedure to be performed in conjunction with esophageal stent placement Patient has a known hypersensitivity or contraindication to study products that, in the opinion of the investigator, cannot be adequately premedicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Esophageal Fistula</keyword>
	<keyword>Esophageal Neoplasms</keyword>
	<keyword>Esophageal Perforation</keyword>
	<keyword>Esophageal Stenosis</keyword>
	<keyword>Stents</keyword>
</DOC>